Utah Medical Products Q3 2024 results referenced but data missing in filing extract

UTAH MEDICAL PRODUCTS INC

2024-Q3 EPS reported $3.10 revenue$31,745,000

8-K filed Oct 29, 2024 furnishes press release for three and nine months ended Sep 30, 2024.
Full financial figures and forward-looking statements are not included in the provided text.
Company ticker: UTMD.

item 2.02 item 9.01 item 99.1

UTAH MEDICAL PRODUCTS INC filing history →

Source: SEC EDGAR

accession 0001096906-24-002035

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.